Gabelli Healthcare & WellnessRx Trust — Form SCHEDULE 13D/A
Filed August 28, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 22/100
What the filing says
Saba Capital Management, L.P. acquired 36,932 common shares of Gabelli Healthcare & WellnessRx Trust between 8/11/2026 and 8/27/2026 through open market purchases at prices ranging from $9.86 to $10.13 per share, totaling approximately $371,400. The purchases were disclosed via Schedule 13D/A amendment on 8/27/2026. No prior ownership percentage or post-transaction stake was specified in the exhibit.
Why this rating
Routine open-market share accumulation by existing investor; no control threshold disclosed; modest dollar size relative to typical closed-end fund scale; no material event trigger evident.
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.